<DOC>
	<DOC>NCT01272986</DOC>
	<brief_summary>This is a trial of screening for ALOA-IgG AtheroAbzyme Test comparing healthy, asymptomatic myocardial ischemic and acute coronary syndrome patients.</brief_summary>
	<brief_title>Trial of Screening for ALOA-IgG AtheroAbzyme Test</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Healthy patients High Risk patients or Asymptomatic myocardial Ischemic patients Acute Coronary Syndrome patients</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Determination of the level of oxidised LDL by measuring the level of IgG in Blood</keyword>
</DOC>